Welcome to our dedicated page for ETRACS Whitney US Critical Technologies ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
Offering overview: UBS AG is marketing unsecured, unsubordinated Trigger Autocallable Contingent Yield Notes linked to the common stock of Palantir Technologies Inc. The Notes are expected to price on 26 Jun 2025, settle on 30 Jun 2025 and mature on or about 30 Jun 2026, unless automatically called earlier.
Key terms:
- Issue price: $10 per Note; minimum purchase 100 Notes ($1,000).
- Contingent coupon: 17.40 %–19.18 % per annum, paid bimonthly only if Palantir’s closing price on the relevant observation date is ≥ the coupon barrier (60 % of the initial level).
- Automatic call: If Palantir’s price on any observation date prior to final valuation is ≥ the initial level, UBS redeems at par plus the due coupon and the transaction terminates.
- Downside protection: At maturity, if not previously called and Palantir’s final price is ≥ the downside threshold (50 % of the initial level), investors receive par; otherwise repayment is reduced one-for-one with the underlying decline, potentially to $0.
- Estimated initial value: $9.54–$9.79, reflecting underwriting discount ($0.125 per Note) and UBS’s internal funding spread.
- Distribution: Notes will not be listed on any exchange; secondary trading (if any) will be at prevailing market prices and may be limited.
Principal risks highlighted by the issuer:
- Market risk identical to holding Palantir below the 50 % downside threshold.
- No assurance of any coupon payments.
- Credit risk of UBS AG; the Notes are purely unsecured obligations.
- Liquidity risk due to absence of an exchange listing and the T+2 initial settlement.
Investor profile: Suitable only for investors who understand structured products, can tolerate a total loss of principal and seek enhanced income in exchange for equity downside risk and issuer credit exposure.